News
The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...
Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...
Today’s White House MAHA Commission report is expected to pull punches on pesticide regulation as Bayer lobbies to limit ...
German pharmaceutical giant Bayer said Tuesday it had struck a deal valued at up to $1.3 billion (1.1 billion euros) with a US ...
From a new frontman at Old Trafford to a potential goalkeeping merry-go-round and a big Liverpudlian exit, here are 10 of the ...
Ademola Lookman has reportedly rejected the idea of joining Arsenal, as he is waiting for another move by Inter Milan. This ...
Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...
It’s 2-0 at Stamford Bridge in Chelsea’s game against Bayer Leverkusen, and it’s Joao Pedro who has scored the second.It came ...
Bayer’s Roundup pesticide is linked with cancer. Its fight to dodge accountability threatens to leave sick people holding the ...
Facing another 61,000 unresolved lawsuits claiming its weedkiller causes cancer, Bayer added $1.2 billion to its glyphosate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results